Articles with "eudragit epo" as a keyword



Photo by freestocks from unsplash

Strategies and mechanisms to improve the printability of pharmaceutical polymers Eudragit® EPO and Soluplus®.

Sign Up to like & get
recommendations!
Published in 2021 at "International journal of pharmaceutics"

DOI: 10.1016/j.ijpharm.2021.120410

Abstract: The poor printability of most pharmaceutical polymers greatly restricts the application of the fused deposition modeling (FDM) technique in the field of personalized pharmaceutical preparations. General strategies to improve printability and provide practical guidelines for… read more here.

Keywords: pharmaceutical polymers; improve printability; eudragit epo; epo soluplus ... See more keywords

Dissolution Behavior of Weakly Basic Pharmaceuticals from Amorphous Dispersions Stabilized by a Poly(dimethylaminoethyl Methacrylate) Copolymer.

Sign Up to like & get
recommendations!
Published in 2022 at "Molecular pharmaceutics"

DOI: 10.1021/acs.molpharmaceut.2c00456

Abstract: Amorphous solid dispersions (ASDs) are a well-documented formulation approach to improve the rate and extent of dissolution for hydrophobic pharmaceuticals. However, weakly basic compounds can complicate standard approaches to ASDs due to pH-dependent solubility, resulting… read more here.

Keywords: eudragit epo; dissolution behavior; amorphous dispersions; dissolution ... See more keywords